公开(公告)号：US09656992B2

公开(公告)日：2017-05-23

申请号：US14771914

申请日：2014-03-05

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： Tao Wang ,  Christopher Allard ,  Paul Michael Scola

IPC: A61K45/06 ,  A61K31/506 ,  C07D401/12 ,  C07D401/14 ,  C07D417/14 ,  C07D413/14 ,  A61K31/5377

CPC classification number: C07D401/12 ,  A61K31/506 ,  A61K31/5377 ,  A61K45/06 ,  C07D401/14 ,  C07D413/14 ,  C07D417/14

Abstract: The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.